Description
FeF™ Benzalkonium Chloride Solution 50% (53/30/15/2) Ph.Eur., USP/NF
CAS No. 8001-54-5.
Custom-designed product consisting of Benzyl (dodecyl) dimethyl ammonium chloride (approx. 53%), Benzyl (tetradecyl) dimethyl ammonium chloride (approx. 30%), Benzyl (hexadecyl) dimethyl ammonium chloride (approx. 15%) and Benzyl (octadecyl) dimethyl ammonium chloride (approx. 2%). Contains approx. 50% active ingredients.
Manufactured in accordance with the cGMP Guideline ICH Q7 for Active Pharmaceutical Ingredients. Analysed according to the current European (Ph.Eur.) and United States (USP/NF) Pharmacopoeias.
Please note that this product is only manufactured to order.
| Packing sizes | Item no. | Product image |
|---|---|---|
| 1 kg bottle | 7800008 |  |
Documentation and services
Certificate of Suitability (CEP/COS)
European Drug Master File (ASMF)
DUNS for US import
GMP Certificate (enter Certificate number DK API-H 00073316 and choose Denmark in the country field list)
Certificate of Analysis (current version of pharmacopoeia)
Datasheet
Customer audits
Stability results
Declarations, statements (TSE/BSE, residual solvents, GMO, allergens, animal testing, etc.)
Reach
Change Notification Statement
Pre-filled Supplier Questionnaire
Impurity profile
Description of the manufacturing process
Process flowchart
Packaging details
Quality agreements
Contact us
Corporate Headquaters
Novo Nordisk Pharmatech A/S
Københavnsvej 216 DK - 4600 Køge
Denmark
Phone: +45 5667 1000
Fax: +45 5667 1001
For complaints or comments about our company or our products, please contact
